Literature DB >> 5932899

Extracutaneous delayed hypersensitivity, particularly in the guinea-pig bladder.

J E Coe, J D Feldman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5932899      PMCID： PMC1423641     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  6 in total

1.  THE IMMUNE RESPONSE IN THE PRESENCE OF DELAYED HYPERSENSITIVITY OF CIRCULATING ANTIBODY.

Authors:  J E COE; S B SALVIN
Journal:  J Immunol       Date:  1964-09       Impact factor: 5.422

2.  Biologic activity of aggregated gamma-globulin. II. A study of various methods for aggregation and species differences.

Authors:  K ISHIZAKA; T ISHIZAKA
Journal:  J Immunol       Date:  1960-08       Impact factor: 5.422

3.  The fate of 131 I-labelled diphtheria toxin and toxoid in the skin of immune and allergic guinea-pigs.

Authors:  D A LONG
Journal:  J Hyg (Lond)       Date:  1959-06

4.  The antibody response of lymph node cells transferred to tolerant recipients.

Authors:  W O WEIGLE; F J DIXON
Journal:  J Immunol       Date:  1959-06       Impact factor: 5.422

5.  The comparative retention of antigen in the skin of immune and normal rabbits as determined with egg albumin labelled with radioactive iodine.

Authors:  L KORNGOLD; G L STAHLY; M C DODD; W G MYERS
Journal:  J Immunol       Date:  1953-04       Impact factor: 5.422

6.  Detection of non-precipitating antibodies in sera of individuals allergic to ragweed pollen by an in vitro method.

Authors:  J GORDON; B ROSE; A H SEHON
Journal:  J Exp Med       Date:  1958-07-01       Impact factor: 14.307
  6 in total
  14 in total

Review 1.  Intravesical therapy for urothelial carcinoma of the urinary bladder: a critical review.

Authors:  Daher C Chade; Shahrokh F Shariat; Guido Dalbagni
Journal:  Int Braz J Urol       Date:  2009 Nov-Dec       Impact factor: 1.541

2.  Experimental immune inflammation in the synovial membrane. I. The immunological mechanism.

Authors:  G Loewi
Journal:  Immunology       Date:  1968-09       Impact factor: 7.397

3.  Update on the management of non-muscle invasive bladder cancer.

Authors:  Saad Aldousari; Wassim Kassouf
Journal:  Can Urol Assoc J       Date:  2010-02       Impact factor: 1.862

4.  Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer.

Authors:  E C De Boer; W H De Jong; P A Steerenberg; L A Aarden; E Tetteroo; E R De Groot; A P Van der Meijden; P D Vegt; F M Debruyne; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

5.  Metabolism of homologous and heterologous serum proteins in garter snakes (Thamnophis ordinoides).

Authors:  D Leong; J E Coe
Journal:  Immunology       Date:  1978-05       Impact factor: 7.397

6.  Presence of interleukin-2 in urine of superficial bladder cancer patients after intravesical treatment with bacillus Calmette-Guérin.

Authors:  W H De Jong; E C De Boer; A P Van der Meijden; P Vegt; P A Steerenberg; F M Debruyne; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

Review 7.  BCG in the treatment of superficial cancer of the bladder: a review.

Authors:  S Friberg
Journal:  Med Oncol Tumor Pharmacother       Date:  1993

8.  Immunological aspects of intravesical administration of Bacillus Calmette-Guérin (BCG) in the guinea pig.

Authors:  A P van der Meijden; W H de Jong; E C de Boer; P A Steerenberg; F M Debruyne; E J Ruitenberg
Journal:  Urol Res       Date:  1989

Review 9.  Use of bacille Calmette-Guérin in superficial bladder cancer.

Authors:  J-P Meyer; R Persad; D A Gillatt
Journal:  Postgrad Med J       Date:  2002-08       Impact factor: 2.401

Review 10.  Treatment of superficial bladder cancer.

Authors:  A Morales
Journal:  Can Med Assoc J       Date:  1980-05-24       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.